Login

I cannot remember my username

Our New Website Is Here!
As part of our merger with St. Paul Research, we’ve created a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through our analysts’ combined insight, expertise, and perspective. Go to my.stpaulresearch.com to access our new site.

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now...

In Breakthrough Technology Alert, Ray Blanco tirelessly researches these exciting new breakthrough technologies and tells you exactly what you need to do to profit from them.

Flash Alert: Grab 388% Profits Now

Ray Blanco
By Ray BlancoPosted December 15, 2020

Psychedelic stocks are heating up! Already one of our positions is up over 50% since we bought in. And today, we have another stock with huge potential. Plus, book nearly 400% profits on one of our open positions!

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

LoginGet Access

Ray Blanco

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Related Posts

Triple-Digit Profits on Tap — This Antibiotic Biotech Is a Great Buy Right Now

Ray Blanco
By Ray BlancoPosted October 9, 2017

We’re up 88% since our original recommendation last year, and there’s still plenty of boom in this biotech. We can expect continued gains as they start filing over the next few months. Plus, our early stage drug development play is pursuing an unexplored avenue in the current medical era… These two could be the perfect cocktail for saving human lives… and bring us a decent profit in the meantime.

TOPICS | , , , , , , , , , , ,

Convergence on Schedule: What You Have to Know to Profit

Patrick Cox
By Patrick CoxPosted June 16, 2009

Dear Breakthrough Technology reader, This week, I’d like to discuss more about the financial implications of the “convergence.” More to the point, I’d like to tell you about the emergence of a few of the companies that will profit from this powerful technological trend. These are not unknown small caps, but are little known outside...

TOPICS | , , ,